Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562
Authors:
- Li LiuLi Liu
- Sitao WangSWSitao Wang
- Renan ChenRCRenan Chen
- Yanlan WuYWYanlan Wu
- Bei ZhangBZBei Zhang
- Siyong HuangSHSiyong Huang
- Jingyi ZhangJZJingyi Zhang
- Fang XiaoFXFang Xiao
- Meng WangMWMeng Wang
- Yingmin LiangYLYingmin Liang
- 1 August 2012
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 425 (2) , 368-373
Abstract
No abstract availableKeywords
Funding Information
- 863 project of China (2006AA02A111)
- National Nature Science Foundation of China (NSFC C03030202)
This publication has 32 references indexed in Scilit:
- MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?Leukemia Research, 2011
- Expression patterns of microRNAs associated with CML phases and their disease related targetsMolecular Cancer, 2011
- c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin ResistanceScience Signaling, 2011
- BCR-ABL1-independent PI3Kinase activation causing imatinib-resistanceJournal of Hematology & Oncology, 2011
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- The functions of animal microRNAsNature, 2004
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damageNature, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001